120 related articles for article (PubMed ID: 29048109)
21. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
22. Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Devillier R; Harbi S; Fürst S; Crocchiolo R; El-Cheikh J; Castagna L; Etienne A; Calmels B; Lemarie C; Prebet T; Granata A; Charbonnier A; Rey J; Chabannon C; Faucher C; Vey N; Blaise D
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1560-5. PubMed ID: 24933658
[TBL] [Abstract][Full Text] [Related]
23. Reduced-intensity conditioning regimens before unrelated cord blood transplantation in adults with acute leukaemia and other haematological malignancies.
Rocha V; Mohty M; Gluckman E; Rio B; ; ;
Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S31-4. PubMed ID: 19561411
[TBL] [Abstract][Full Text] [Related]
24. Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe.
Rafii H; Ruggeri A; Kenzey C; Sanz J; Peffault De La Tour R; Esquirol A; Michel G; Chevallier P; Rubio MT; Cornelissen JJ; Michallet M; Volt F; Rivera-Franco MM; Scigliuolo GM; Cappelli B; Rocha V; Gluckman E
Blood Adv; 2023 May; 7(10):1976-1986. PubMed ID: 36350759
[TBL] [Abstract][Full Text] [Related]
25. A Study of Human Leukocyte Antigen Mismatched Cellular Therapy (Stem Cell Microtransplantation) in High-Risk Myelodysplastic Syndrome or Transformed Acute Myelogenous Leukemia.
Hu KX; Sun QY; Guo M; Qiao JX; Yu CL; Qiao JH; Dong Z; Sun WJ; Zuo HL; Huang YJ; Cai B; Ai HS
Stem Cells Transl Med; 2016 Apr; 5(4):524-9. PubMed ID: 26838271
[TBL] [Abstract][Full Text] [Related]
26. [Clinical effect of umbilical cord blood transplantation in 37 pediatric patients with hematologic malignancies: a single-center experience].
Luan Z; Tang XF; Wu NH; Xu SX; Zhang B; Wang K; Du H
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):714-9. PubMed ID: 25008879
[TBL] [Abstract][Full Text] [Related]
27. Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies.
Rocha V; Labopin M; Ruggeri A; Podestà M; Gallamini A; Bonifazi F; Sanchez-Guijo FM; Rovira M; Socie G; Baltadakis I; Michallet M; Deconinck E; Bacigalupo A; Mohty M; Gluckman E; Frassoni F
Transplantation; 2013 May; 95(10):1284-91. PubMed ID: 23507699
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO).
Basquiera AL; Rivas MM; Remaggi G; Klein G; Milovic V; Foncuberta MC; Saba S; Milone JH; Arbelbide J; Jaimovich G; Rolón JM; Kusminsky G; García JJ; Prates MV
Hematology; 2016 Apr; 21(3):162-9. PubMed ID: 26147089
[TBL] [Abstract][Full Text] [Related]
29. Comparison of cord blood transplantation with unrelated bone marrow transplantation in patients older than fifty years.
Tanaka M; Miyamura K; Terakura S; Imai K; Uchida N; Ago H; Sakura T; Eto T; Ohashi K; Fukuda T; Taniguchi S; Mori S; Nagamura-Inoue T; Atsuta Y; Okamoto S
Biol Blood Marrow Transplant; 2015 Mar; 21(3):517-25. PubMed ID: 25498906
[TBL] [Abstract][Full Text] [Related]
30. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
[TBL] [Abstract][Full Text] [Related]
31. Late-onset colitis after cord blood transplantation is consistent with graft-versus-host disease: results of a blinded histopathological review.
Milano F; Shulman HM; Guthrie KA; Riffkin I; McDonald GB; Delaney C
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1008-13. PubMed ID: 24704386
[TBL] [Abstract][Full Text] [Related]
32. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
[TBL] [Abstract][Full Text] [Related]
33. Comparison of graft-versus-host disease-free, relapse-free survival according to a variety of graft sources: antithymocyte globulin and single cord blood provide favorable outcomes in some subgroups.
Inamoto Y; Kimura F; Kanda J; Sugita J; Ikegame K; Nakasone H; Nannya Y; Uchida N; Fukuda T; Yoshioka K; Ozawa Y; Kawano I; Atsuta Y; Kato K; Ichinohe T; Inoue M; Teshima T;
Haematologica; 2016 Dec; 101(12):1592-1602. PubMed ID: 27662017
[TBL] [Abstract][Full Text] [Related]
34. Cord blood transplantation in children with haematological malignancies.
Bertaina A; Bernardo ME; Caniglia M; Vinti L; Giorgiani G; Locatelli F
Best Pract Res Clin Haematol; 2010 Jun; 23(2):189-96. PubMed ID: 20837330
[TBL] [Abstract][Full Text] [Related]
35. Comparison of Outcomes of 8/8 and 7/8 Allele-Matched Unrelated Bone Marrow Transplantation and Single-Unit Cord Blood Transplantation in Adults with Acute Leukemia.
Terakura S; Atsuta Y; Tsukada N; Kobayashi T; Tanaka M; Kanda J; Najima Y; Fukuda T; Uchida N; Takahashi S; Nagamura-Inoue T; Morishima Y; Miyamura K;
Biol Blood Marrow Transplant; 2016 Feb; 22(2):330-338. PubMed ID: 26476205
[TBL] [Abstract][Full Text] [Related]
36. Comparison of unrelated cord blood and peripheral blood stem cell transplantation in adults with myelodysplastic syndrome after reduced-intensity conditioning regimen: a collaborative study from Eurocord (Cord blood Committee of Cellular Therapy & Immunobiology Working Party of EBMT) and Chronic Malignancies Working Party.
Robin M; Ruggeri A; Labopin M; Niederwieser D; Tabrizi R; Sanz G; Bourhis JH; van Biezen A; Koenecke C; Blaise D; Tischer J; Craddock C; Maillard N; Mohty M; Russel N; Schetelig J; Finke J; Gluckman E; de Witte TM; Rocha V; Kroger N
Biol Blood Marrow Transplant; 2015 Mar; 21(3):489-95. PubMed ID: 25529382
[TBL] [Abstract][Full Text] [Related]
37. The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies.
Choe HK; Gergis U; Mayer SA; Nagar H; Phillips AA; Shore TB; Smith MJ; van Besien K
Transplantation; 2017 Jan; 101(1):e34-e38. PubMed ID: 27764032
[TBL] [Abstract][Full Text] [Related]
38. Cytogenetics and comorbidity predict outcomes in older myelodysplastic syndrome patients after allogeneic stem cell transplantation using reduced intensity conditioning.
Yucel OK; Saliba RM; Rondon G; Ahmed S; Alousi A; Bashir Q; Ciurea SO; Popat U; Khouri I; Marin D; Rezvani K; Kebriaei P; Shpall EJ; Champlin RE; Oran B
Cancer; 2017 Jul; 123(14):2661-2670. PubMed ID: 28324640
[TBL] [Abstract][Full Text] [Related]
39. Development and validation of a disease risk stratification system for patients with haematological malignancies: a retrospective cohort study of the European Society for Blood and Marrow Transplantation registry.
Shouval R; Fein JA; Labopin M; Cho C; Bazarbachi A; Baron F; Bug G; Ciceri F; Corbacioglu S; Galimard JE; Giebel S; Gilleece MH; Giralt S; Jakubowski A; Montoto S; O'Reilly RJ; Papadopoulos EB; Peric Z; Ruggeri A; Sanz J; Sauter CS; Savani BN; Schmid C; Spyridonidis A; Tamari R; Versluis J; Yakoub-Agha I; Perales MA; Mohty M; Nagler A
Lancet Haematol; 2021 Mar; 8(3):e205-e215. PubMed ID: 33636142
[TBL] [Abstract][Full Text] [Related]
40. Refined Disease Risk Index for Hematological Malignancies, Including Rare Disorders, After Allogeneic Stem Cell Transplantation.
Fujiwara S; Hattori N; Matsui T; Nakata A; Sasaki Y; Shimada S; Murai S; Abe M; Baba Y; Watanuki M; Kawaguchi Y; Arai N; Kabasawa N; Tsukamoto H; Uto Y; Yanagisawa K; Harada H; Nakamaki T
Transplant Proc; 2019 Dec; 51(10):3437-3443. PubMed ID: 31733801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
